aromasil has been researched along with Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maurya, P; Mishra, N; Nisha, R; Pal, RR; Parashar, P; Saraf, SA; Singh, N; Singh, P | 1 |
| Ajipa, O; Andre, F; Beck, JT; Blumenstein, L; Curigliano, G; Donnet, V; Fazio, N; Hubner, RA; Jhaveri, K; Lahner, H; Li, Z; Martin, M; Maur, M; Tortora, G | 1 |
| Abrantes, AM; Botelho, MF; Gonçalves, C; Marques, IA; Matafome, P; Pires, AS; Rodrigues, T; Roleira, FMF; Tavares-da-Silva, E; Varela, CL | 1 |
| Adachi, Y; Andoh, M; Gondo, N; Hagiwara, S; Hattori, M; Hijioka, S; Iwata, H; Kotani, H; Mizuno, Y; Sawaki, M; Shimizu, J; Tachi, M; Tatematsu, M; Yoshimura, A; Yoshimura, K | 1 |
2 trial(s) available for aromasil and Neoplasms
| Article | Year |
|---|---|
Alpelisib in combination with everolimus ± exemestane in solid tumours: Phase Ib randomised, open-label, multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Europe; Everolimus; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Thiazoles; Treatment Outcome; United States | 2021 |
A single-arm, phase 2 study of steroid-containing mouthwash for the prevention of everolimus-associated stomatitis in multiple tumor types.
Topics: Adult; Aged; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Everolimus; Female; Humans; Male; Middle Aged; Mouthwashes; Neoplasms; Prognosis; Prospective Studies; Quality of Life; Steroids; Stomatitis | 2019 |
2 other study(ies) available for aromasil and Neoplasms
| Article | Year |
|---|---|
QbD-assisted development of lipidic nanocapsules for antiestrogenic activity of exemestane in breast cancer.
Topics: Androstadienes; Animals; Lipids; Liposomes; Nanocapsules; Neoplasms | 2023 |
Oxymestane, a cytostatic steroid derivative of exemestane with greater antitumor activity in non-estrogen-dependent cell lines.
Topics: Androstadienes; Antineoplastic Agents; Cell Cycle; Cell Line; Cell Proliferation; Cell Survival; Cytostatic Agents; DNA Damage; Estrogens; Humans; Membrane Potential, Mitochondrial; Neoplasms; Protein Serine-Threonine Kinases | 2021 |